Invasix announces UK launch of Votiva

Invasix will be launching Votiva in to the UK market. Designed to improve feminine health concerns, Votiva includes two handpieces – FormaV and FractoraV – to provide internal and external treatment, with a resurfacing and/or non-invasive option.

FormaV uses uniform RF to address all areas of labial hypertrophy and vaginal laxity. The versatility of the FormaV allows the operator to provide a customised solution to address the variety of feminine health concerns that occur due to ageing, hormonal changes, or physical damage. Patients often see results immediately, with continued results over the following weeks.

FractoraV uses customised fractional RF energy to improve superficial skin tone problems (skin texture) and deep concerns (deep heating and tightening) through resurfacing. The bi-polar RF treatment allows clinicians to accurately treat a targeted zone for a precise non-invasive treatment. The full depth heating can improve elastin and collagen remodelling to positively impact women’s feminine health and quality of life.